Summary
TFX Chart
Teleflex Q1 Earnings Beat, '25 EPS View Down, Stock Up
TFX benefits from a diversified product portfolio in the first quarter of 2025, with strength in the Surgical and Interventional segments.
Teleflex Incorporated (TFX) Q1 2025 Earnings Call Transcript
Teleflex Incorporated (NYSE:TFX ) Q1 2025 Results Conference Call May 1, 2025 8:00 AM ET Company Participants Lawrence Keusch - VP-IR & Strategy Development Liam Kelly - Chairman, President & Chief Executive Officer John Deren - Executive VP & Chief Financial Officer Conference Call Participants Patrick Wood - Morgan Stanley Michael Sarcone - Jefferies Jayson Bedford - Raymond James Vikramjeet Singh Chopra - Wells Fargo Matthew O'Brien - Piper Sandler Anthony Petrone - Mizuho Group Shagun Singh - RBC Richard Newitter - Truist Securities Craig Bijou - Bank of America Michael Polark - Wolfe Research Mike Matson - Needham Operator Good morning, ladies and gentlemen, and welcome to the Teleflex First Quarter 2025 Earnings Conference Call. [Operator Instructions] Please note that this conference call is being recorded, and we will be available on the company's website for replay shortly.
Here's What Key Metrics Tell Us About Teleflex (TFX) Q1 Earnings
While the top- and bottom-line numbers for Teleflex (TFX) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Teleflex Inc. Dividends
 TFX In 1 month Estimated | Quarterly | $0.34 Per Share |
| TFX 1 month ago Paid | Quarterly | $0.34 Per Share |
| TFX 4 months ago Paid | Quarterly | $0.34 Per Share |
| TFX 8 months ago Paid | Quarterly | $0.34 Per Share |
| TFX 11 months ago Paid | Quarterly | $0.34 Per Share |
| TFX 14 May 2024 Paid | Quarterly | $0.34 Per Share |
Teleflex Inc. Earnings
| 30 Jul 2025 (In 1 week) Date | | 3.36 Cons. EPS | - EPS |
| 30 Apr 2025 Date | | - Cons. EPS | - EPS |
| 20 Feb 2025 Date | | 3.88 Cons. EPS | 3.89 EPS |
| 31 Oct 2024 Date | | 3.39 Cons. EPS | 3.49 EPS |
| 1 Aug 2024 Date | | 3.33 Cons. EPS | 3.42 EPS |
| TFX In 1 month Estimated | Quarterly | $0.34 Per Share |
| TFX 1 month ago Paid | Quarterly | $0.34 Per Share |
| TFX 4 months ago Paid | Quarterly | $0.34 Per Share |
| TFX 8 months ago Paid | Quarterly | $0.34 Per Share |
| TFX 11 months ago Paid | Quarterly | $0.34 Per Share |
| TFX 14 May 2024 Paid | Quarterly | $0.34 Per Share |
| 30 Jul 2025 (In 1 week) Date | | 3.36 Cons. EPS | - EPS |
| 30 Apr 2025 Date | | - Cons. EPS | - EPS |
| 20 Feb 2025 Date | | 3.88 Cons. EPS | 3.89 EPS |
| 31 Oct 2024 Date | | 3.39 Cons. EPS | 3.49 EPS |
| 1 Aug 2024 Date | | 3.33 Cons. EPS | 3.42 EPS |
Teleflex Inc. (TFX) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
What is the earnings per share?
When is the next earnings date?
Has Teleflex Inc. ever had a stock split?
Teleflex Inc. Profile
| Medical - Instruments & Supplies Industry | Healthcare Sector | Liam J. Kelly CEO | NYSE Exchange | 879369106 Cusip |
| US Country | 14,100 Employees | 20 May 2025 Last Dividend | 17 Jun 1997 Last Split | 18 Feb 1988 IPO Date |
Overview
Teleflex Incorporated is a global leader in the development, manufacturing, and supply of single-use medical devices for diagnostic and therapeutic procedures in critical care and surgical applications. The company has a rich history dating back to 1943 and is headquartered in Wayne, Pennsylvania. Serving hospitals, healthcare providers, medical device manufacturers, and the home care market, Teleflex aims to improve the health and quality of life of patients worldwide with its innovative medical technologies.
Products and Services
- Vascular Access Products: Includes Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems, designed for the administration of intravenous therapies, blood pressure measurement, and the withdrawal of blood samples through a single puncture site.
- Interventional Products: Comprises a range of coronary catheters, structural heart support devices, and peripheral intervention and mechanical circulatory support platforms. These are utilized by interventional cardiologists, radiologists, and vascular surgeons and include Arrow branded pumps and catheters, Guideline, Turnpike, and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices.
- Anesthesia Products: Offers airway and pain management products that support hospital, emergency medicine, and military channels, ensuring the patient's comfort and safety during medical procedures.
- Surgical Products: Provides metal and polymer ligation clips and fascial closure surgical systems for use in laparoscopic surgeries, percutaneous surgical systems, and a range of other surgical instruments, enabling surgeons to perform with precision and efficiency.
- Interventional Urology Products: Features the UroLift System, an innovative technology for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia, offering a minimally invasive alternative to traditional procedures.
- Respiratory Products: Includes oxygen and aerosol therapies, spirometry, and ventilation management products for various care settings, aiding in the respiratory care of patients across a broad spectrum of care environments.
- Urology Products: Offers a comprehensive range of catheters, urine collectors, catheterization accessories, and products for operative endourology, supporting the needs of patients with urologic conditions.
- Bladder Management Services: Provides a suite of services and products for effective bladder management, enhancing the quality of life for patients dealing with bladder-related health issues.
Contact Information
